Regeneron Pharmaceuticals (REGN) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.84% |
| Dec 31, 2025 | -10.98% |
| Sep 30, 2025 | 3.53% |
| Jun 30, 2025 | 17.76% |
| Mar 31, 2025 | -6.00% |
| Dec 31, 2024 | -25.61% |
| Sep 30, 2024 | -6.35% |
| Jun 30, 2024 | -22.68% |
| Mar 31, 2024 | -13.49% |
| Dec 31, 2023 | 0.30% |
| Sep 30, 2023 | 6.17% |
| Jun 30, 2023 | 2.57% |
| Mar 31, 2023 | 9.40% |
| Dec 31, 2022 | 14.76% |
| Sep 30, 2022 | 25.25% |
| Jun 30, 2022 | 64.02% |
| Mar 31, 2022 | 28.29% |
| Dec 31, 2021 | 39.54% |
| Sep 30, 2021 | 40.01% |
| Jun 30, 2021 | 77.79% |
| Mar 31, 2021 | 32.63% |
| Dec 31, 2020 | 87.80% |
| Sep 30, 2020 | 29.44% |
| Jun 30, 2020 | 32.27% |
| Mar 31, 2020 | 35.89% |
| Dec 31, 2019 | 46.27% |
| Sep 30, 2019 | 36.24% |
| Jun 30, 2019 | -0.53% |
| Mar 31, 2019 | 36.48% |
| Dec 31, 2018 | 74.28% |
| Sep 30, 2018 | 41.39% |
| Jun 30, 2018 | 41.50% |
| Mar 31, 2018 | 84.57% |
| Dec 31, 2017 | 47.61% |
| Sep 30, 2017 | 67.00% |
| Jun 30, 2017 | 59.06% |
| Mar 31, 2017 | 53.89% |
| Dec 31, 2016 | 43.20% |
| Sep 30, 2016 | 23.29% |
| Jun 30, 2016 | 30.95% |
| Mar 31, 2016 | 22.42% |
| Dec 31, 2015 | -30.93% |
| Sep 30, 2015 | 3.19% |
| Jun 30, 2015 | 36.37% |
| Mar 31, 2015 | 86.86% |
| Dec 31, 2014 | -38.72% |
| Sep 30, 2014 | 49.43% |
| Jun 30, 2014 | 52.43% |
| Mar 31, 2014 | 52.87% |
| Dec 31, 2013 | 99.20% |
| Sep 30, 2013 | 83.43% |
| Jun 30, 2013 | 75.77% |
| Mar 31, 2013 | 73.68% |
| Dec 31, 2012 | 138.59% |
| Sep 30, 2012 | 475.53% |
| Jun 30, 2012 | 92.54% |